Extractos Ecuatorianos Ingandu S.A.S. Company Profile - Ecuador | Financials & Key Executives

Extractos Ecuatorianos Ingandu S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing

Secondary Activities: Basic Chemical Manufacturing | Medicinal and Botanical Manufacturing | Toilet Preparation Manufacturing | Other Chemical Product and Preparation Manufacturing

Full name: Extractos Ecuatorianos Ingandu S.A.S.

Profile Updated: May 15, 2024

Extractos Ecuatorianos Ingandu S.A.S. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on June 16, 2021. Extractos Ecuatorianos Ingandu S.A.S. currently employs 4 (2021) people. Its’ total assets recorded a growth of 120.77%.

Headquarters
N34b Guayas E3-112
Quito; Pichincha;

Contact Details: Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.

Outstanding Shares:

Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.

Registered Capital:

Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.

Incorporation Date:

June 16, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

51%

Purchase this report to view the information.

49%

Company Performance

Financial values in the chart are available after Extractos Ecuatorianos Ingandu S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-11.78%▼

EBITDA

71.67%▲

Net Profit (Loss) for the Period

-11.76%▼

Total assets

120.77%▲

Total equity

-734.43%▼

Return on Equity (ROE)

-98.03%▼

Quick Ratio

-0.01%▼

Cash Ratio

-0.05%▼

Similar companies

Related EMIS Industry Reports